Radiotherapy Devices Market Inclinations & Development Status Highlighted for the Forecast Period between 2017 to 2022
Improving the quality of life of cancer patients and survivors is becoming more important than the efficacy of treatments. Against the backdrop of health risks associated with prominent cancer treatment procedures such as chemotherapy, patients and oncologists are turning towards radiotherapy as the most soothing option in treatment of cancers. In the years to come, the global cancer incidence rate is expected to soar uncontrollably, particularly due to emergence of new complications arising from exposure of toxic materials. The demand for radiotherapy devices will continue to grow in parallel with the adoption of radiotherapy in treatment of cancers. Reduced hospital stay, effectively control over the growth of tumorous tissues, and low exposure to undue radiation are serving as proponents of using radiotherapy devices in oncological treatment of cancer. Going forward, the global market for radiotherapy devices is expected to witness higher participation of medical device manufacturers towards product innovation.
Radiotherapy devices are a wide range of medical devices used in radiation therapy. These devices can produce accurate amount of high-energy radiation, which is further delivered on targeted areas of the patient’s body. General characteristics of a radiotherapy device include emission of electrons, photons and other fast-moving subatomic particles, and the use of x-ray tubes to build contact between the device and the targeted area in the patient’s body.
The Fact.MR report on global market for radiotherapy devices projects that by the end of 2022, more than US$ 7 Bn worth of radiotherapy devices will be sold across the globe, reflecting an impressive market expansion at stellar CAGR.
High Demand for Linear Accelerator Devices
With continued advancements in medical technology, linear accelerator devices have emerged to become top-selling products in the global market for radiotherapy devices. Viewed as the most-advanced radiotherapy devices, linear accelerators produce radiation and deliver it precisely in critical procedures such as intensity modulated radiation therapy and intraoperative radiation therapy. In 2017, more than US$ 2 Bn worth of linear accelerators are expected to be sold in the global radiotherapy device market.
For more Information on this Report, click @ https://www.factmr.com/report/77/radiotherapy-devices-market
Oncological Treatment Centers to Boost the use of Radiotherapy Devices
Increasing preference to radiotherapy for oncological treatment of cancers is expected to influence the end-use of radiotherapy devices in specialty centers. The report predicts that hospitals will remain the largest end-users of radiotherapy devices, and also projects a soaring rise in the end-use of radiotherapy devices across oncological treatment centers in the world. Against the background of high medical costs, adoption of radiotherapy devices becomes cost-effective for oncological treatment centers. In addition this, the demand for radiotherapy devices in oncological treatment of cancers is also expected to incur influence from advantage of radiotherapy in controlling the growth of carcinogenic cells & tissues. By the end of 2022, more than US$ 1.9 Bn worth of radiotherapy devices will be sold in the global market across oncological treatment centers.
Competition Tracking
Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd. are key companies that are expected to remain active in the expansion of global radiotherapy devices market through 2022.
Radiotherapy devices are a wide range of medical devices used in radiation therapy. These devices can produce accurate amount of high-energy radiation, which is further delivered on targeted areas of the patient’s body. General characteristics of a radiotherapy device include emission of electrons, photons and other fast-moving subatomic particles, and the use of x-ray tubes to build contact between the device and the targeted area in the patient’s body.
The Fact.MR report on global market for radiotherapy devices projects that by the end of 2022, more than US$ 7 Bn worth of radiotherapy devices will be sold across the globe, reflecting an impressive market expansion at stellar CAGR.
High Demand for Linear Accelerator Devices
With continued advancements in medical technology, linear accelerator devices have emerged to become top-selling products in the global market for radiotherapy devices. Viewed as the most-advanced radiotherapy devices, linear accelerators produce radiation and deliver it precisely in critical procedures such as intensity modulated radiation therapy and intraoperative radiation therapy. In 2017, more than US$ 2 Bn worth of linear accelerators are expected to be sold in the global radiotherapy device market.
For more Information on this Report, click @ https://www.factmr.com/report/77/radiotherapy-devices-market
Oncological Treatment Centers to Boost the use of Radiotherapy Devices
Increasing preference to radiotherapy for oncological treatment of cancers is expected to influence the end-use of radiotherapy devices in specialty centers. The report predicts that hospitals will remain the largest end-users of radiotherapy devices, and also projects a soaring rise in the end-use of radiotherapy devices across oncological treatment centers in the world. Against the background of high medical costs, adoption of radiotherapy devices becomes cost-effective for oncological treatment centers. In addition this, the demand for radiotherapy devices in oncological treatment of cancers is also expected to incur influence from advantage of radiotherapy in controlling the growth of carcinogenic cells & tissues. By the end of 2022, more than US$ 1.9 Bn worth of radiotherapy devices will be sold in the global market across oncological treatment centers.
Competition Tracking
Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd. are key companies that are expected to remain active in the expansion of global radiotherapy devices market through 2022.
Comments
Post a Comment